Israel Englander Alaunos Therapeutics, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.04 - $0.13 $1,561 - $5,073	39,030 Added 63.26%	100,730 $7,000
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.65 $199,179 - $301,084	-463,207 Reduced 88.25%	61,700 $31,000
Q1 2023 May 15, 2023	BUY	$0.46 - $0.81 $66,090 - $116,375	143,674 Added 37.69%	524,907 $331,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $261.0 $190,616 - $99.5 Million	381,233 New	381,233 $247,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $1.24 $667,354 - $2.02 Million	1,627,693 Added 300.31%	2,169,705 $2.69 Million
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $836,370 - $1.58 Million	-1,348,984 Reduced 71.34%	542,012 $354,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $992,051 - $1.72 Million	910,139 Added 92.79%	1,890,996 $2.06 Million
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $880,840 - $1.67 Million	611,695 Added 165.7%	980,857 $1.79 Million
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $970,896 - $1.35 Million	369,162 New	369,162 $975,000
Q1 2021 May 17, 2021	SELL	$2.82 - $5.6 $2.32 Million - $4.61 Million	-823,361 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $174,920 - $258,614	83,694 Added 11.32%	823,361 $2.08 Million
Q3 2020 Nov 16, 2020	SELL	$2.39 - $3.43 $1.41 Million - $2.02 Million	-590,192 Reduced 44.38%	739,667 $1.86 Million
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $2.85 Million - $4.81 Million	1,297,143 Added 3964.86%	1,329,859 $4.36 Million
Q1 2020 May 14, 2020	SELL	$1.9 - $4.98 $2.61 Million - $6.85 Million	-1,374,697 Reduced 97.68%	32,716 $80,000
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $4.57 Million - $6.19 Million	1,157,307 Added 462.73%	1,407,413 $6.64 Million
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $408,601 - $686,608	-98,935 Reduced 28.34%	250,106 $1.07 Million
Q2 2019 Aug 15, 2019	BUY	$3.98 - $6.2 $1.1 Million - $1.71 Million	275,995 Added 377.84%	349,041 $2.04 Million
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $290,723 - $452,885	73,046 New	73,046 $2.77 Million
Q4 2018 Feb 14, 2019	SELL	$1.61 - $3.62 $17,293 - $38,882	-10,741 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.26 - $3.27 $24,274 - $35,123	10,741 New	10,741 $34,000
Q1 2018 May 15, 2018	SELL	$3.46 - $5.14 $36,800 - $54,669	-10,636 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$4.0 - $6.54 $704,116 - $1.15 Million	-176,029 Reduced 94.3%	10,636 $44,000
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $931,458 - $1.23 Million	186,665	186,665 $1.15 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account